BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pabinger I, Ay C, Dunkler D, Thaler J, Reitter EM, Marosi C, Zielinski C, Mannhalter C. Factor V Leiden mutation increases the risk for venous thromboembolism in cancer patients - results from the Vienna Cancer And Thrombosis Study (CATS). J Thromb Haemost 2015;13:17-22. [PMID: 25381723 DOI: 10.1111/jth.12778] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Falanga A, Schieppati F, Russo L. Pathophysiology 1. Mechanisms of Thrombosis in Cancer Patients. In: Soff G, editor. Thrombosis and Hemostasis in Cancer. Cham: Springer International Publishing; 2019. pp. 11-36. [DOI: 10.1007/978-3-030-20315-3_2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
2 Alexander M, Pavlakis N, John T, O'Connell R, Kao S, Hughes BGM, Lee A, Hayes SA, Howell VM, Clarke SJ, Millward M, Burbury K, Solomon B, Itchins M. A multicenter study of thromboembolic events among patients diagnosed with ROS1-rearranged non-small cell lung cancer. Lung Cancer 2020;142:34-40. [PMID: 32087434 DOI: 10.1016/j.lungcan.2020.01.017] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
3 Hotoleanu C. Genetic Risk Factors in Venous Thromboembolism. Adv Exp Med Biol 2017;906:253-72. [PMID: 27638626 DOI: 10.1007/5584_2016_120] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 4.6] [Reference Citation Analysis]
4 Heraudeau A, Delluc A, Le Henaff M, Lacut K, Leroyer C, Desrues B, Couturaud F, Tromeur C. Risk of venous thromboembolism in association with factor V leiden in cancer patients - The EDITH case-control study. PLoS One 2018;13:e0194973. [PMID: 29775482 DOI: 10.1371/journal.pone.0194973] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
5 Heenkenda MK, Malmström A, Lysiak M, Mudaisi M, Bratthäll C, Milos P, Strandeus M, Åkesson L, Söderkvist P, Uppugunduri S, Osman A. Assessment of genetic and non-genetic risk factors for venous thromboembolism in glioblastoma - The predictive significance of B blood group. Thromb Res 2019;183:136-42. [PMID: 31677594 DOI: 10.1016/j.thromres.2019.10.009] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
6 Giurgea G, Brunner-ziegler S, Jilma B, Sunder-plassmann R, Koppensteiner R, Gremmel T. Plasminogen activator inhibitor-1 4G/5G genotype and residual venous occlusion following acute unprovoked deep vein thrombosis of the lower limb: A prospective cohort study. Thrombosis Research 2017;153:71-5. [DOI: 10.1016/j.thromres.2017.03.017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
7 Ulrych J, Kvasnicka T, Fryba V, Komarc M, Malikova I, Brzezkova R, Kvasnicka Jr J, Krska Z, Briza J, Kvasnicka J. The impact of hereditary thrombophilia on the incidence of postoperative venous thromboembolism in colorectal cancer patients: a prospective cohort study: Hereditary thrombophilia and VTE in colorectal cancer surgery. Eur Surg 2019;51:5-12. [DOI: 10.1007/s10353-018-0534-0] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Aydin H, Gunay M, Celik G, Gunay BO, Aydin UT, Karaman A. Evaluation of Factor V Leiden, Prothrombin G20210A, MTHFR C677T and MTHFR A1298C gene polymorphisms in retinopathy of prematurity in a Turkish cohort. Ophthalmic Genet 2016;37:415-8. [PMID: 27018927 DOI: 10.3109/13816810.2015.1126611] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
9 Reddington H, Ballinger Z, Abghari M, Modukuru V, Wallack M. Sclerosing Mesenteritis in a Patient Heterozygous for Factor V Leiden. Am J Case Rep 2020;21. [DOI: 10.12659/ajcr.926332] [Reference Citation Analysis]
10 O'Malley TJ, Sooppan R, Yeo CJ. Perioperative Management of Factor V Leiden and Pancreatic Adenocarcinoma. J Pancreat Cancer 2017;3:53-7. [PMID: 30631843 DOI: 10.1089/pancan.2017.0010] [Reference Citation Analysis]
11 Castellón Rubio VE, Segura PP, Muñoz A, Farré AL, Ruiz LC, Lorente JA. High plasma levels of soluble P-Selectin and Factor VIII predict venous thromboembolism in non-small cell lung cancer patients: The Thrombo-Nsclc risk score. Thromb Res 2020;196:349-54. [PMID: 32977135 DOI: 10.1016/j.thromres.2020.09.021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Ay C, Pabinger I, Cohen AT. Cancer-associated venous thromboembolism: Burden, mechanisms, and management.Thromb Haemost. 2017;117:219-230. [PMID: 27882374 DOI: 10.1160/TH16-08-0615] [Cited by in Crossref: 158] [Cited by in F6Publishing: 68] [Article Influence: 26.3] [Reference Citation Analysis]
13 Hohaus S, Bartolomei F, Cuccaro A, Maiolo E, Alma E, D'Alò F, Bellesi S, Rossi E, De Stefano V. Venous Thromboembolism in Lymphoma: Risk Stratification and Antithrombotic Prophylaxis. Cancers (Basel) 2020;12:E1291. [PMID: 32443753 DOI: 10.3390/cancers12051291] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Gran OV, Smith EN, Brækkan SK, Jensvoll H, Solomon T, Hindberg K, Wilsgaard T, Rosendaal FR, Frazer KA, Hansen JB. Joint effects of cancer and variants in the factor 5 gene on the risk of venous thromboembolism. Haematologica 2016;101:1046-53. [PMID: 27479824 DOI: 10.3324/haematol.2016.147405] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
15 Ferrer Galván M, Sánchez López V, Otero Candelera R. Prognostic Factors for Thrombosis in Cancer Patients. Arch Bronconeumol (Engl Ed) 2019;55:67-8. [PMID: 30100207 DOI: 10.1016/j.arbres.2018.07.006] [Reference Citation Analysis]
16 Paulsen B, Skille H, Smith EN, Hveem K, Gabrielsen ME, Brækkan SK, Rosendaal FR, Frazer KA, Gran OV, Hansen JB. Fibrinogen gamma gene rs2066865 and risk of cancer-related venous thromboembolism. Haematologica 2020;105:1963-8. [PMID: 31582554 DOI: 10.3324/haematol.2019.224279] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
17 Amiral J, Vissac AM, Seghatchian J. Laboratory assessment of Activated Protein C Resistance/Factor V-Leiden and performance characteristics of a new quantitative assay. Transfus Apher Sci 2017;56:906-13. [PMID: 29162399 DOI: 10.1016/j.transci.2017.11.021] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
18 Ferroni P, Palmirotta R, Riondino S, De Marchis ML, Nardecchia A, Formica V, Guadagni F, Roselli M. VEGF gene promoter polymorphisms and risk of VTE in chemotherapy-treated cancer patients. Thromb Haemost 2016;115:143-51. [PMID: 26336029 DOI: 10.1160/TH15-03-0259] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Ünlü B, Versteeg HH. Cancer-associated thrombosis: The search for the holy grail continues. Res Pract Thromb Haemost 2018;2:622-9. [PMID: 30349879 DOI: 10.1002/rth2.12143] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
20 Salla E, Dimakakos EP, Tsagkouli S, Giozos I, Charpidou A, Kainis E, Syrigos KN. Venous Thromboembolism in Patients Diagnosed With Lung Cancer. Angiology 2016;67:709-24. [PMID: 26553057 DOI: 10.1177/0003319715614945] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
21 Buijs JT, Versteeg HH. Genes and proteins associated with the risk for cancer-associated thrombosis. Thrombosis Research 2020;191:S43-9. [DOI: 10.1016/s0049-3848(20)30396-0] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Muñoz Martín AJ, Ortega I, Font C, Pachón V, Castellón V, Martínez-Marín V, Salgado M, Martínez E, Calzas J, Rupérez A, Souto JC, Martín M, Salas E, Soria JM. Multivariable clinical-genetic risk model for predicting venous thromboembolic events in patients with cancer. Br J Cancer 2018;118:1056-61. [PMID: 29588512 DOI: 10.1038/s41416-018-0027-8] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 10.3] [Reference Citation Analysis]
23 Moik F, Ay C, Pabinger I. Risk prediction for cancer-associated thrombosis in ambulatory patients with cancer: past, present and future. Thrombosis Research 2020;191:S3-S11. [DOI: 10.1016/s0049-3848(20)30389-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 3.5] [Reference Citation Analysis]
24 Gran OV, Brækkan SK, Hansen J. Prothrombotic genotypes and risk of venous thromboembolism in cancer. Thrombosis Research 2018;164:S12-8. [DOI: 10.1016/j.thromres.2017.12.025] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
25 Gerotziafas GT, Elalamy I. [Risk of venous thromboembolism in cancer patients: Reality, actuality and perspectives]. Bull Cancer 2016;103:764-75. [PMID: 27481723 DOI: 10.1016/j.bulcan.2016.07.001] [Reference Citation Analysis]
26 Grilz E, Marosi C, Königsbrügge O, Riedl J, Posch F, Lamm W, Lang IM, Pabinger I, Ay C. Association of complete blood count parameters, d-dimer, and soluble P-selectin with risk of arterial thromboembolism in patients with cancer. J Thromb Haemost 2019;17:1335-44. [PMID: 31099477 DOI: 10.1111/jth.14484] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
27 Vorobev A, Makatsariya A, Bitsadze V, Khizroeva J, Solopova A. Unusual thrombosis or pregnancy complications associated to ovarian cancers: two clinical cases. J Matern Fetal Neonatal Med 2021;34:1430-4. [PMID: 31258012 DOI: 10.1080/14767058.2019.1638359] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
28 Hisada Y, Geddings JE, Ay C, Mackman N. Venous thrombosis and cancer: from mouse models to clinical trials. J Thromb Haemost. 2015;13:1372-1382. [PMID: 25988873 DOI: 10.1111/jth.13009] [Cited by in Crossref: 75] [Cited by in F6Publishing: 67] [Article Influence: 10.7] [Reference Citation Analysis]